CAR-T Therapy Helps Kids Battling Deadly Nervous System Tumors
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Monthly Injections Might Lower Bleeding in People With Hemophilia
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Personalized ctDNA Monitoring Can Predict Outcomes in Advanced Melanoma
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
BioMarin, as expected, sees delay to FDA review of hemophilia gene therapy
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
TECH Radioligand therapy, a ‘game-changer’ for cancer treatment, forces manufacturers to race against a ticking clock
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Top 10 most anticipated drug launches of 2023
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Pfizer’s hemophilia B gene therapy is better than standard of care in phase 3 trial
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Early Win for Gene Therapy in Rare Form of SCID — 10 infants were able to make their own T cells; safety good so far
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
